CHARACTERISTICS OF CLINICAL, SUBCLINICAL AND RESULTS OF TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY IN PATIENTS WITH PSA HIGHER THAN 4NG/ML
Main Article Content
Abstract
Background: Prostate cancer is one of the most common cancers in men, accounting for about 15% of all cancers. Definitive diagnosis needs to be based on many factors such as: digital rectal examination, blood PSA, prostate biopsy results. To diagnose prostate cancer early and understand the correlations between clinical symptoms (digital rectal examination), subclinical symptoms (total PSA, ultrasound) and prostate biopsy results, we conduct this study. Objective: To investigate the clinical and subclinical characteristics of prostate cancer patients with PSA higher than 4ng/ml and the correlation between them in the diagnosis and treatment of prostate cancer. prostate. Materials and methods: This is a cross-sectional, prospective study on 112 prostate cancer patients who were eligible for biopsies from March 2021 to March 2023 at the Hospital of Can Tho University of Medicine and Pharmacy. Results: The mean age was 71.48 ± 9.58 years old, the main cause for admission was difficulty in urination 72.30%. The mean total PSA was 97.77 ± 238.27 ng/ml. Prostate cancer detection rate after biopsy reached 35.7% (40/112). The level of differentiation according to the Gleason scale of high malignancy accounts for 52.5%. There was 1 case of severe rectal bleeding and 1 case of severe hematuria stabilized by aggressive medical treatment and blood transfusion. Conclusions: Prostate biopsy is an accurate method in diagnosing prostate cancer and is a safe procedure that can be widely used in qualified medical facilities.
Article Details
Keywords
Rectal prostate biopsy, prostate cancer, PSA higher than 4ng/ml
References
2. Stephen J, Humana P, Totowa, NJ. Minimizing pain and optimizing patient experience during prostate biopsy. Prostate biopsy.2008.11.124-128, http://doi.org/10.1007/978-1-60327-0786_11.
3. Justin S, Brian L. M, Vidhya K, Abhinav S. A review of optimal prostate biopsy: indications and techniques. Ther Adv Urol.2019.11.1-8, http://doi.org/10.1177/1756287219870074.
4. Phan Văn Hoàng, Nguyễn Văn Học, Nguyễn Chí Phong. Sinh thiết tuyến tiền liệt 12 mẫu qua ngã trực tràng tại bệnh viện Bình Dân. Y học TP. Hồ Chí Minh.2010.14(1).448-451, http://yhoctphcm.ump.edu.vn/index.php?Content=ChiTietBai&idBai=7753.
5. Nguyễn Trung Hiếu, Trần Văn Nguyên, Trần Huỳnh Tuấn, Lê Quang Trung, Quách Võ Tấn Phát và cộng sự. Đặc điểm lâm sàng, cận lâm sàng và kết quả sinh thiết tuyến tiền liệt 12 mẫu dưới hướng dẫn của siêu âm qua ngả trực tràng tại Bệnh viện Đại học Y Dược Cần Thơ. Tạp chí Y Dược Học Cần Thơ.2022.55.73-80, https://tapchi.ctump.edu.vn/index.php/ctump/article/view/383/370.
6. Vũ Trung Kiên. Nghiên cứu ứng dụng phương pháp sinh thiết tuyến tiền liệt 12 mẫu dưới hướng dẫn của siêu âm qua trực tràng trong chẩn đoán ung thư tuyến tiền liệt. Trường Đại học Y Hà Nội.2020.127.
7. Jerome. P. R, William J. C, Frederick R. A, M’Liss A. H, Peter T. S, et al. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology.1993.42.365, http://doi.org/10.1016/0090-4295(93)90359-i.
8. Martin G, Mark B, Leland C. Prostate Cancer. Advances in Oncobiology.1996.1.257-291, http://doi.org/10.1016/S1569-254X(96)80014-8.
9. Fang J, Metter E. J, Chan D. W, Morrel C. H, Carter H. B. Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging. Urology.2001.58.411-416, http://doi.org/10.1016/s0090-4295(01)01304-8.
10. Jacques F, Isabelle S, Rajesh D, Sultan E, Colin M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J
Cancer.2015.136(5). E359 – 386, http://doi.org/ 10.1002/ijc.29210.